 EXETER, N.H.--BUSINESS WIRE--Vapotherm, Inc. NYSE: VAPO, Vapotherm or the Company, today announced it has received 510k clearance from the US Food and Drug Administration for HVT 2.0. This next generation system is designed to provide high velocity therapy using an integrated air source, eliminating the need for wall air or any pressurized air source. It is estimated that 50 of U.S. hospital beds dont have wall air. When paired with an oxygen source, the HVT 2.0 will support patie 